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Osseointegrated prosthesis for
patients with an amputation
Multidisciplinary team approach in the
Netherlands
Referral and assessment
People with a lower limb amputation
who encounter problems with their
socket prosthesis present to our clinic
via diﬀerent routes. When the ortho-
pedic technicians are unable to make
a suitable socket, they usually refer the
person to the treating rehabilitation
consultant. All rehabilitation physicians
in the Netherlands who are specialized
in amputation are aware of the possi-
bility of an osseointegration prosthesis
(OIP) and refer patients to our cen-
ter for further assessment. More and
more patients are becoming informed
through social media and are asking
their general practitioner for a refer-
ral to our clinic. In addition, a small
group of people are referred by their
surgeon. In recent years, an increas-
ing number of patients are also sent
to our center from abroad, sometimes
spurred by our international website
and scientiﬁc publications [https://www.
radboudumc.nl/Zorg/Behandelingen/
Pages/Osseointegration.aspx]. Patients
additionally contact our clinic immedi-
ately after amputation to inquire about
their eligibility for OIP treatment and to
skip rehabilitation with a socket pros-
thesis. So far, our policy is to complete
rehabilitation with a socket prosthesis
and to only consider OIP after socket-
related problems have been demon-
strated [7].
Patients who are referred for OIP
treatment are invited by our case man-
ager to multidisciplinary group clinics.
Prior to their visit, patient are asked to
complete the Questionnaire for Persons
with a Transfemoral Amputation (Q-
TFA) [8]. The outpatient consultation
that occurs once a month starts with
standard radiographs collected in two
directions, including a calibrated total
view of both lower extremities, prefer-
ably in the upright position (. Fig. 1a, b).
In patients with transtibial amputation,
a CT scan is performed to allow the
design of patient-speciﬁc implants. Sub-
sequently, patients and their companions
are introduced to two OIP experts who
were formerly treated at our center.
These experts inform new patients about
their experiences with the OIP treatment
and what the new patients can expect
regarding living with an OIP. Follow-
ing the agenda of that day, a plenary
presentation is performed for the entire
group of OIP candidates by the surgeon
and rehabilitation physician, in which
all the details of the OIP treatment are
discussed interactively. Finally, individ-
ual consultations with the OIP treatment
team are performed, including a com-
plete assessment of medical history,
a physical examination, the Q-TFA, and
radiography to reach a consensus about
the indication for OIP treatment based
on shared decision making. The OIP
treatment team includes an orthope-
dic surgeon, a rehabilitation physician,
a physiotherapist, and an orthopedic
technician. When a patient’s medical
history reveals a psychiatric history,
a clinical psychologist is also consulted
to assess the patient prior to inclusion.
In2009,OIPtreatmentwasstillassoci-
atedwithariskofosteitisorosteomyelitis,
so we only included patients with a lower
limb amputation caused by trauma or
a tumor in OIP treatment because we
assumed that the patients in this cate-
gory would have a relatively low risk of
infection. Evaluation of the ﬁrst 84 pa-
tients with an OIP in this low-risk cat-
egory conﬁrmed that the risk of osteitis
or osteomyelitis was low [1]. In 2014,
we decided to also include patients with
lower limb amputation due to periph-
eral vascular disease and/or diabetes to
qualify for an OIP. Future evaluation will
show whether OIP treatment is safe in
these patients with a higher average age,
comorbidity and an increased risk of in-
fections. The health beneﬁts of an OIP
in this category of patients are probably
high because it is known that enhanced
mobility is associated with higher life ex-
pectancy [5].
Osseointegration systems
There are currently two registered OIP
systems: the OPRA system (Integrum®)
[4] and the Endo-Exo/ILP system (Eska/
OrthoDynamics/Permedica) [6]. The
OPRA system is derived from dental
implants and consists of a titanium
intramedullary implant (ﬁxture) with
a length of 80mm that is connected to
a transcutaneous abutment. The cylin-
drical ﬁxture is inserted into the marrow







cavity of the femur as a screw and needs
6 months for proper osseointegration
[9]. The Endo-Exo/ILP system con-
sists of a 140 to 180mm-long, slightly
curved chromium–cobalt–molybdenum
or titanium stem with a macroporous or
roughly coated surface that is hammered
to be press ﬁt in the medullary cavity and
that allows loading within 6–8 weeks [3].
Full weight bearing is already possible
after 8–12 weeks with the Endo-exo/ILP
system compared with the OPRA sys-
tem, which allows for full weight bearing
after 6–12 months [13]. Because of the
shorter osseointegration/rehabilitation
period, we chose the Endo-Exo/ILP sys-
tem for procedures performed in the
Netherlands. The surgical procedure
includes two operations [2]: in the ﬁrst
operation, the intramedullary implant is
inserted in combination with a stump
revision, and 6–8 weeks later, the second
operation is scheduled for insertion of




denum cast stem in the Endo-exo/ILP
system is covered with a macroporous
coating of 1.5mm thickness (tripods),
reducing the core diameter of the femoral
stem by 3mm. After breakage of two
Endo-Exo/ILP stems within 3 years after
implantation, in 2015, we decided to
proceed with a newly designed forged
titanium implant system (OPL) man-
ufactured with a thin plasma-sprayed
coating and a standard length of 160mm
(Permedica, Sydney Australia). As for
the chromium–cobalt–molybdenum
stem, there is a distal niobium pol-
ished extramedullary head (OPL type A,
. Fig. 2a). For distal transfemoral ampu-
tations, there is also an intramedullary
distal head (OPL type B, . Fig. 2b). For
patients with femur remnants of less
than 160mm (. Fig. 2c) and for patients
with transtibial amputation, we use cus-
tom-made implants with locking screws
for primary stabilisation. These short
implants are covered with a 0.5mm
macroporous 3D mesh coating for rapid
osseointegration (. Fig. 2d, e). Custom-
made implants are designed in collabo-
ration with engineers from the Radboud
University Medical Centre 3D Labora-
tory (Nijmegen, The Netherlands) and
physicians of the osseointegration team
based on standard CT scans applied
in a graphic design program. The de-
sign is then fabricated with a titanium
3D printer for further processing and
coating.
Preoperative planning
For patients after midshaft or distal
transfemoral amputation, we analyze
calibrated digital radiographs using or-
thopedic software to calculate thedimen-
sions of the femoral implant (IMPAX
Client AGFA, Rijswijk, The Nether-
lands). From standing full-leg-length
radiographs, we determine whether the
femoral remnant is to be shortened for
implantation of the femoral stem. Based
on the limb subject to the axis of ro-
tation of the OIP, the OIP is brought
ﬂush with the axis of rotation of the
knee on the side that was not amputated.
The minimum construction height of
the Endo-Exo/ILP system, including the
transcutaneous dual cone adapter com-
ponent and the external connector, is
160mm. Calculated from the contralat-
eral medial knee joint, knee or distal
transfemoral amputations have to be
shortened 160mm at most.
Surgical protocol
The OIP system is applied via two op-
erations in the Netherlands. Both op-
erations are carried out in accordance
with the international standard orthope-
dic protocol used in hip and knee re-
placements, including perioperative in-
travenous antibiotic prophylaxis. The
ﬁrst operation includes an adjustment of
the stump, with reduction of the soft tis-
sue and possible shortening of the femur.
Then, the medullary canal is opened and
is reamedand rasped to thedesireddiam-
eter in a retrograde manner. After select-
ing the correct implant size, the press-ﬁt
294 Der Unfallchirurg 4 · 2017
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coatedstemisinsertedbygentlehammer-
ing. Primary stability is achieved by the
slight curvature of the implant within the
anatomical antecurvation of the femoral
shaft in type A implants. Tibial implants
and patients speciﬁc implants for short
femoral remnants, primarystability is en-
sured by locking screws. Prior to the ﬁnal
insertion, the dorsal and ventral muscle
groups of the thigh are connected to the
distal femoral cortex with sutures to con-
struct a myodesis. The future stoma site
is prepared by removal of subcutaneous
adipose tissue, and the skin is closed. All
patients are dismissed on postoperative
day three or four. In the period up to
the second operation, no socket prosthe-
sis can be used to optimize the wound
healing. Mobilization must occur using
crutches or a wheelchair. The artiﬁcial
leg that was previously connected to the
socket is collectedby theorthopedic tech-
nician to mount the click safety connec-
tor for the osseointegration system (OTN
Wijchen, The Netherlands). The second
operation is planned for 6–8 weeks after
the implantation of the intramedullary
femoral stem and includes a small proce-
dure that involves the creation of a stoma
by cutting a circular (diameter of 20 mm)
skin incision at the location of the head
of the femoral stem. The transcutaneous
component (dual cone) of the OIP sys-
tem is placed in the head of the femoral
stem and ﬁxed with a locking screw.
Until 2012, we did not remove sub-
cutaneous fat when preparing the stoma,
and certain patients needed surgical re-
fashioning of the stoma because it pro-
duced discharge due to mechanical fric-
tionbetween the soft tissue and the trans-
cutaneous component (. Fig. 3a). This
discharge had to be collected with gauze,
which was ﬁxed with a silicone cap to
prevent loss of moisture via contact with
clothing (‘wet’ stoma). In an attempt
to prevent these secondary refashioning
eﬀects and also to simplify stoma care,
we adjusted our technique to include the
construction of a myodesis at stage one
as well as removal of subcutaneous fat to
prepare the stoma (. Fig. 3b). As a result,
insteadof the transcutaneous component
of the system being introduced through
the muscle and subcutaneous fat layers,
only skin covers the intramedullary stem.
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Osseointegrated prosthesis for patients with an amputation.
Multidisciplinary team approach in the Netherlands
Abstract
This article reviews the development of
multidisciplinary osseointegration treatment
in the Netherlands since its start in 2009.
People experiencing limitations due to their
socket prosthesis after a leg amputation
present to the Radboud University Nijmegen
Medical Centre for an osseointegration
implant or “bone-anchored” prosthesis. In
this article we share our experiencewith the
ﬁrst 100 patients regarding referral pattern,
selection criteria, available osseointegration
systems, preoperative planning, surgical
treatment, the rehabilitation protocol,
outcomemeasurement, revision surgery, and
future developments.
Keywords
Amputation · Osseointegration · Bone-
anchored prosthesis · Rehabilitation ·
Multidisciplinary approach
Osseointegrierte Prothese für Patienten nach Amputation.
Multidisziplinärer Behandlungsansatz in den Niederlanden
Zusammenfassung
Der Beitrag fasst die Entwicklung der
multidisziplinären Osseointegrationsbe-
handlung in den Niederlanden seit ihren
Anfängen im Jahr 2009 zusammen. Patienten
nach Beinamputation, die durch ihre
stumpfumfassende Prothese eingeschränkt
sind, stellen sich im Radboud University
Nijmegen Medical Centre vor, um ein
osseointegrierendes Implantat oder eine
„knochenverankerte“ Prothese zu erhalten.
Wir berichten über unsere Erfahrungen
mit den ersten 100 Patienten. Thematisiert
werden Einweisungsmuster, Auswahlkrite-
rien, verfügbare Osseointegrationssysteme,





Amputation · Osseointegration · Knochen-
verankerte Prothese · Rehabilitation ·
Multidisziplinärer Ansatz
This approach has resulted in a shorter
range of the transcutaneous component
in the soft tissue, resulting in less pain,
lessabscess formation, and lowerproduc-
tion of discharge from the stoma (‘dry’
stoma). Future research should deter-
mine whether this surgical adjustment
will have the desired eﬀect.
Analogous to developments in dental
implantology, there are also initiatives
for femoral and tibial osseointegration
systems to be implemented via one op-
eration (single-stage method) [14, 15].
This approach, of course, has an impor-
tant advantage in that there is only one
surgery needed, instead of two, with a re-
duction of treatment time. In certain
(tibia) cases, the soft tissue covering the
stump is so thin that treatment in two
stages is technicallynotpossible. In those
cases, the placement of the transcuta-
neous component, usually occurring in
stage two, is performed in the ﬁrst opera-
tion. Theoriginal idea forperforming the
OIP placement in two stages is to allow
bony ingrowth of the femoral stemunder
sterile conditions. Adequate osseointe-
gration of the implant prevents any infec-
tion from ascending from the stoma and
entering the marrow cavity. In the case
of single-stage procedures, the transcu-
taneous component of the OIP system
is theoretically under nonsterile condi-
tions during the osseointegration period,
with a consequently possibly higher risk
of osteomyelitis and septic loosening. To
date, standard OIP treatment is carried
out in two stages at our clinic. Further re-
search will indicate whether single-stage
OIP treatment is safe enough to oﬀer as
standard procedure.
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Fig. 28 Examples of various implants available:aOPL type Awith a distal niobiumpolished extramedullary head,bOPL
type Bwith an intramedullary distal head, c,d, e custom-made implantswithmacroporous 3Dmesh coating for accelerated
osseointegration
Fig. 39 a Schematic
representation of a ‘wet’
stoma,b schematic repre-
sentation of a ‘dry’ stoma
Rehabilitation protocol
The ﬁrst session of rehabilitation follow-
ing OIP treatment starts one week af-
ter the second operation. The rehabil-
itation is conducted by our multidisci-
plinary team twice a week with groups
of 6–8 patients. The osseointegration re-
habilitation team includes a rehabilita-
tion physician, a physical therapist, an
occupational therapist, and a prosthetic
technician. Patients with a psychiatric
historyalso receive cotherapy fromaclin-
ical psychologist, if needed. During the
ﬁrst session, the transcutaneous compo-
nent of the OIP system is attached to the
external prosthesis by means of a click
safety adapter by the prosthetic techni-
cian, with adjustment andultimate align-
ment at a later stageduring rehabilitation.
The physical therapist provides instruc-
tionsfortransitioningfrompartialweight
bearing towalkingwith full loading, with
symmetrical walking as the ultimate goal
[11]. The occupational therapist pro-
vides instructions for daily stoma care.
The rehabilitation physician supervises
the entire rehabilitation and treats ini-
tial stoma complaints with prescriptions
of painkillers or antibiotics, if needed.
In cases of a tibial OIP, the duration of
the total rehabilitation is approximately
4 weeks. In femoral cases, the rehabili-
tation is at least 4 weeks long. An inter-
lude is initiated if muscle pain or limited
muscle strength is an obstacle to further
progression to full loading. In the in-
terlude, patients walk with two crutches
and cover walking distances at their own
speed, depending on pain. The rehabil-
itation sessions are resumed when the
patients are able to walk approximately
50–100mwithminimal support fromthe
crutches. This part of the rehabilitation
program focuses on walking longer dis-
tances without crutches and optimizing
gait symmetry. For rehabilitation after
OIP treatment, pain is typically in the
distal stump, at the site of the myodesis.
Only when the myodesis is very strong
can the stumpmuscles optimally stabilize
the femur, with gradual disappearance of
the pain in the muscles and attachments.
In most patients, it takes approximately
one year after implantation to reach that
desired level [16].
Pre–post outcomemeasures
To evaluate functional outcomes in a sys-
tematic manner both preoperatively and
at 6 months and 1, 2, 5, and 10 years af-
ter OIP placement, speciﬁc instruments
are used to evaluate performance. The
Q-TFA is used to evaluate the prosthesis
wearing time, mobility, and prosthesis-
related quality of life [8]. Activities are
assessedwith the timedupandgo test and
the 6-minute walk test. For all patients,
the pre–post outcome data and compli-
cations are recorded in a certiﬁed web-
based data management system (https://
nl.castoredc.com) [12]. Standard con-
ventional radiographs are used to assess
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bone remodeling at 1 and 2 years after
OIP surgery.
Revision of OIP system
The intramedullary component of the
OIP system has to be replaced in cases of
(a)septic loosening or implant breakage
[1]. Similar to the replacement of a hip or
knee prosthesis, it is technically possible
to remove the intramedullarycomponent
of an OIP system and to replace it with
anew implant. In sucha revision, thedis-
tal head is sawed oﬀ the intramedullary
component and subsequently removed
with anoversized corer inevitably remov-
ing a small amount of cortical bone from
the inner cortical wall. Research by our
group has shown that periprosthetic cor-
tical bone increases over the years, which
facilitates surgical removal of the stem
[10]. To allow the cortical wall to heal
and to optimize osseointegration poten-
tial, we tend to wait 6 months to redo
the stem implantation.
Future developments
At this time, OIP treatment is applied to
patients with problems that are related to
the prosthesis socket [12]. Based on the
favorable results with regard to security,
mobility and quality of life, we expect
an increasing number of patients eligible
for OIP treatment to be treatable simul-
taneously with or directly after amputa-
tion, without socket adjustments. More-
over, patients with only slight socket-
related complaints and patients who de-
mand high-performance prosthesis will
be eligible for OIP treatment. In addi-
tion, more patients with a lower limb
amputation due to peripheral vascular
disease and/or diabetes will be eligible
for OIP treatment. The development
of a standard tibial OIP system, rather
than a labor- and time-intensive cus-
tom-made osseointegration system, will
improve the quality of care and reduce
healthcare costs. More and more people
with transtibial amputation will qualify
for an OIP in the future. Our osseoin-
tegration group is currently developing
a standard tibial implant that meets the
qualiﬁcation for European Conformity
(CE marking). In addition, the femoral
OIP system will be further optimized so
that the standard implant canalsobeused
in patients with a shorter femur remnant.
Practical conclusion
4 Osseointegration prostheses (OIP)
can be safely used in patients having
problems related to the prosthesis
socket.
4 The associated risk for osteitis and
osteomyelitis is low in patients with
amputation due to trauma or tumor.
The risk in other groups of patients
(e.g., peripheral vascular disease,
diabetes) is being evaluated.
4 Standard length (140 or 160mm) im-
plants are available for transfemoral
amputations; custom-made implants
can be made for shorter remnants or
for transtibial amputations.
4 Total rehabilitation time approxi-
mately 4 weeks; interludes taken
as needed due to muscle pain or
inadequate muscle strength.
4 Patients with OIP have improved
mobility and quality of life.
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Lebensqualität, klinische Ergebnisse und





In der Auﬂistung der Ein- und Auss-
chlusskriterien zur beschriebenen Studie
(. Tab. 1) ist ein Fehler aufgetreten. Wir
bittendiekorrektenAngabenzubeachten
und entschuldigen uns für den Fehler.
Tab. 1 Ein- undAusschlusskriterien dieser Studie
Einschlusskriterien Ausschlusskriterien
Lebensalter ≥65 Jahre Pathologische Frakturen
Nichtrekonstruierbare dislozierte 3- und
4-Fragment-Frakturen
Hochrasanztraumata
Niedrigrasanztraumata (z. B. Sturz auf ebener
Fläche)
Mehrfachverletzungen (Polytraumata)
Keine schwere kognitive Dysfunktion Relevante Begleiterkrankungen (z. B.
N.-axillaris-Läsionen, Infektionen)
Follow-up ≥ 12 Monate Schwere Demenz (Mini-Mental-Status-Test
[MMST] < 10 Punkte)
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